Global Influenza Diagnostics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Influenza Diagnostics market size will reach 3,005.47 Million USD in 2025 and is projected to reach 4,564.07 Million USD by 2032, with a CAGR of 6.15% (2025-2032). Notably, the China Influenza Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Influenza diagnostics refer to the methods and tools used for the detection and identification of the influenza virus, which causes the contagious respiratory illness known as the flu. These diagnostics play a crucial role in healthcare settings, aiding in the timely identification of influenza infections for proper patient management, treatment decisions, and public health surveillance. Common influenza diagnostic methods include molecular techniques such as polymerase chain reaction (PCR) to detect viral genetic material, rapid influenza diagnostic tests (RIDTs) that provide quick results based on antigen detection, and viral culture for isolating and identifying the virus. The choice of diagnostic method depends on factors such as speed, accuracy, and the specific healthcare context. Influenza diagnostics are particularly important during flu seasons and outbreaks, helping to control the spread of the virus and inform vaccination strategies.
The major global suppliers of Influenza Diagnostics include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Influenza Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Influenza Diagnostics Include:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Influenza Diagnostics Product Segment Include:
RIDT
RT-PCR
Cell Culture
Others
Influenza Diagnostics Product Application Include:
Hospitals
POCT
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Diagnostics Industry PESTEL Analysis
Chapter 3: Global Influenza Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Influenza Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Influenza Diagnostics market size will reach 3,005.47 Million USD in 2025 and is projected to reach 4,564.07 Million USD by 2032, with a CAGR of 6.15% (2025-2032). Notably, the China Influenza Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Influenza diagnostics refer to the methods and tools used for the detection and identification of the influenza virus, which causes the contagious respiratory illness known as the flu. These diagnostics play a crucial role in healthcare settings, aiding in the timely identification of influenza infections for proper patient management, treatment decisions, and public health surveillance. Common influenza diagnostic methods include molecular techniques such as polymerase chain reaction (PCR) to detect viral genetic material, rapid influenza diagnostic tests (RIDTs) that provide quick results based on antigen detection, and viral culture for isolating and identifying the virus. The choice of diagnostic method depends on factors such as speed, accuracy, and the specific healthcare context. Influenza diagnostics are particularly important during flu seasons and outbreaks, helping to control the spread of the virus and inform vaccination strategies.
The major global suppliers of Influenza Diagnostics include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Influenza Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Influenza Diagnostics Include:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Influenza Diagnostics Product Segment Include:
RIDT
RT-PCR
Cell Culture
Others
Influenza Diagnostics Product Application Include:
Hospitals
POCT
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Diagnostics Industry PESTEL Analysis
Chapter 3: Global Influenza Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Influenza Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Influenza Diagnostics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Influenza Diagnostics Product by Type
- 1.2.1 RIDT
- 1.2.2 RT-PCR
- 1.2.3 Cell Culture
- 1.2.4 Others
- 1.3 Influenza Diagnostics Product by Application
- 1.3.1 Hospitals
- 1.3.2 POCT
- 1.3.3 Others
- 1.4 Global Influenza Diagnostics Market Size Analysis (2020-2032)
- 1.5 Influenza Diagnostics Market Development Status and Trends
- 1.5.1 Influenza Diagnostics Industry Development Status Analysis
- 1.5.2 Influenza Diagnostics Industry Development Trends Analysis
- 2 Influenza Diagnostics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Influenza Diagnostics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Influenza Diagnostics Market Analysis by Country
- 4.1 Global Influenza Diagnostics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Influenza Diagnostics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Influenza Diagnostics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Influenza Diagnostics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Influenza Diagnostics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Influenza Diagnostics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Influenza Diagnostics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Influenza Diagnostics Market Analysis by Type
- 6.1 Global Influenza Diagnostics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Influenza Diagnostics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 BD
- 7.1.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 BD Influenza Diagnostics Product Portfolio
- 7.1.3 BD Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Abbott (Include Alere)
- 7.2.1 Abbott (Include Alere) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Abbott (Include Alere) Influenza Diagnostics Product Portfolio
- 7.2.3 Abbott (Include Alere) Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Roche
- 7.3.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Roche Influenza Diagnostics Product Portfolio
- 7.3.3 Roche Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 SIEMENS
- 7.4.1 SIEMENS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 SIEMENS Influenza Diagnostics Product Portfolio
- 7.4.3 SIEMENS Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Analytik Jena
- 7.5.1 Analytik Jena Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Analytik Jena Influenza Diagnostics Product Portfolio
- 7.5.3 Analytik Jena Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Quidel
- 7.6.1 Quidel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Quidel Influenza Diagnostics Product Portfolio
- 7.6.3 Quidel Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Thermo Fisher
- 7.7.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Thermo Fisher Influenza Diagnostics Product Portfolio
- 7.7.3 Thermo Fisher Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Meridian Bioscience
- 7.8.1 Meridian Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Meridian Bioscience Influenza Diagnostics Product Portfolio
- 7.8.3 Meridian Bioscience Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 BioMerieux
- 7.9.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 BioMerieux Influenza Diagnostics Product Portfolio
- 7.9.3 BioMerieux Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Sekisui Diagnostics
- 7.10.1 Sekisui Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Sekisui Diagnostics Influenza Diagnostics Product Portfolio
- 7.10.3 Sekisui Diagnostics Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Response Biomedical
- 7.11.1 Response Biomedical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Response Biomedical Influenza Diagnostics Product Portfolio
- 7.11.3 Response Biomedical Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 SA Scientific
- 7.12.1 SA Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 SA Scientific Influenza Diagnostics Product Portfolio
- 7.12.3 SA Scientific Influenza Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Influenza Diagnostics Industry Chain Analysis
- 8.2 Influenza Diagnostics Product Downstream Application Analysis
- 8.2.1 Global Influenza Diagnostics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Influenza Diagnostics Revenue and Forecast by Application (2020-2032)
- 8.3 Influenza Diagnostics Typical Downstream Customers
- 8.4 Influenza Diagnostics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
